Monoamine oxidase A inhibition by fluoxetine: An in vitro and in vivo study

Synapse

Volumn 31, Issue 4, 1999, Pages 285-289

  Mukherjee, Jogeshwar ^a,b   Yang, Zhi Ying ^a  

^a Franklin McLean Memorial Research Institute   (United States)

^b KETTERING MEDICAL CENTER   (United States)

Author keywords

18F fluoroclorgyline; Fluoxetine (Prozac); Monoamine oxidase A; Norfluoxetine

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CITALOPRAM; CLORGYLINE; FLUOROCLORGYLINE F 18; FLUOXETINE; MONOAMINE OXIDASE A INHIBITOR; N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE; NORFLUOXETINE; RADIOLIGAND; SELEGILINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN HOMOGENATE; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRAIN; CLORGYLINE; FLUOXETINE; LIGANDS; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033559021     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19990315)31:4<285::AID-SYN6>3.0.CO;2-5     Document Type: Article

References (21)

1. Caccia S, Cappi M, Fracasso C, Garattini S. 1990. Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology 100:509-514.
2. Cooper JR, Bloom FE, Roth RH. 1996. The biochemical basis of neuropharmacology, 7th ed. New York: Oxford University Press, p 487-495.
3. Fowler CJ, Tipton KF. 1984. On the substrate specificities of the two forms. J Pharm Pharmacol 36:111-115.
4. Garcia-Colunga J, Awad JN, Miledi R. 1997. Blockade of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 94:2041-2044.
5. Gurevich EV, Joyce JN. 1996. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain. Neuropsychopharmacology 14: 309-323.
6. Holt A, Baker GB. 1996. Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine. Naunyn-Schmiedeberg's Arch Pharmacol 354:17-24.
7. Johnston JP. 1968. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17:1285-1297.
8. Karson CN, Newton JEO, Livingston R, Jolly JB, Cooper TB, Sprigg J, Komoroski RA. 1993. Human brain fluoxetine concentrations. J Neuropsychiatry Clin Neurosci 5:322-329.
9. Lavoie PA, Beauchamp G, Elie R. 1997. Atypical antidepressants inhibit depolarization-induced calcium uptake in rat hippocampus synaptosomes. Can J Physiol Pharmacol 75:983-987.
10. Leonardi ETK, Azmitia EC. 1994. MDMA (Ecstasy) inhibition of MAO type A and type B: Comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacology 10:231-238.
11. Mukherjee J, Yang ZY. 1997. Evaluation of monoamine oxidase B inhibition by fluoxetine (Prozac): An in vitro and in vivo study. Eur J Pharmacol 337:111-114.
12. 18F-Prozac) in the rodent brain: An in vitro and in vivo study. Nucl Med Biol 25:605-610.
13. Munson PJ, Rodbard D. 1980. LIGAND: A versatile approach for the characterisation of ligand binding systems. Anal Biochem 107:220-239.
14. Ni YG, Miledi R. 1997. Blockade of 5HT2C serotonin receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 94:2036-2040.
15. Ohmono Y, Hirata M, Murakami K, Magata Y, Tanaka C, Yokoyama A. 1991. Synthesis of fluorine and iodine analogues of clorgyline and selective inhibition of monoamine oxidase A. Chem Pharm Bull 39:1038-1040.
16. Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch C 3rd. 1998. Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharm Exp Ther 284:208-214.
17. Richelson E. 1994. Pharmacology of antidepressants: characteristics of the ideal drug. Mayo Clin Proc 69:1069-1081.
18. Saura J, Kettler R, Da Prada M, Richards JG. 1992. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: Localization and abundance of MAO-A and MAO-B in rat CNS. peripheral organs, and humans. J Neurosci 12:1977-1999.
19. Stanford SC. 1996. Prozac: panacea or puzzle? Trends Pharm Sci 17:150-154.
20. Wong DT, Bymaster FP, Reid LR, Mayle DA, Krushinski JH, Robertson DW. 1993. Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain. Neuropsychopharmacology 8:337-344.
21. Wong DT, Bymaster FP, Engleman EA. 1995. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug; twenty years since its first publication. Life Sci 57:411-441.